Why Is Nektar Therapeutics $NKTR Stock Down -19.70% Today? (Find out why any stock moved today on Tickeron.) • Shares of $NKTR tumbled roughly 19.7% on Thursday, falling from a prior close of $60.55 to about $48.62. • The slide followed the company's presentation of rezpegaldesleukin (REZPEG) data at the EADV 2026 congress, which confirmed durable responses but pushed the pivotal alopecia areata program into early 2027. • Encouraging durability data was offset by a very small off-treatment patient cohort and a longer-than-expected road to commercialization. • Lingering safety skepticism and the company's legal dispute with Eli Lilly added to the negative sentiment. • Investors are now watching upcoming pivotal-trial milestones and the next quarterly earnings report. $ABVX $SLNO $PALI $APGE $CRVS $OCUL $QURE
published
Why Is Nektar Therapeutics $NKTR Stock Down -19.70% Today? (Find out why any stock moved today on Tickeron.) • Shares of $NKTR tumbled roughly 19.7% on Thursday, falling from a prior close of $60.55 to about $48.62. • The slide followed the company's presentat
$NKTR$ABVX$SLNO$PALI$APGE$CRVS$OCUL$QURE
Latest documented BWB result
$NCPL · $GCDT · $SUNE market result
Here is my September recap 💥 Entry top percentage of move For sure i didn’t hold the full move on all of them, and for sure i got hit with a lot of losses, but i always manage to have a plan, stick to it, minimize losse…
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.